InfuSystem Holdings, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from InfuSystem Holdings, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Profit Cash Ratio: Over the last 3 years, every $100 of reported profit came with $570 of operating cash. Higher than 97% of Healthcare companies in United States.
- Steadiness Ratio: Sales and profit both grew in each of the last 3 years. Steadier than 96% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$570Over the last 3 years, every $100 of reported profit came with $570 of operating cash.
Higher than 97% of Healthcare companies in United States.
Self-Funding Ratio
1.5×Over the last 3 years its own operating cash covered its investment spending (capex) 1.5 times.
Higher than 71% of Healthcare companies in United States.
Cash Locked Ratio
$12For every $100 of sales, $12 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $12 tied up three years earlier.
Less money tied up than 75% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 96% of Healthcare companies in United States.
Growth Efficiency Ratio
$20Sales grew 30% in 3 years; of every extra $100 of sales, $20 became extra profit.
Higher than 51% of Healthcare companies in United States.
Asset Productivity Ratio
+30% / +1%In 3 years sales changed by +30% while total assets changed by +1%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
−7%Debt, after subtracting cash, equals 7% of its market value (net debt).
Lower than 76% of Healthcare companies in United States.
Tangible Assets Ratio
89%Of every $100 the company owns, $89 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 61% of Healthcare companies in United States.
Tangible Net Worth Ratio
82%Of every $100 of net worth, $82 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 63% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
InfuSystem Holdings, Inc. owes $0.39 for every $1 it owns. Net profit rose 183% in the year to Dec 2025, and grew 617% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
35.4Investors pay $35.4 for every $1 of InfuSystem Holdings, Inc.'s yearly profit, higher than 64% of Healthcare companies in United States.
P/B ratio
4.76The share price is 4.76 times InfuSystem Holdings, Inc.'s book value per share, higher than 70% of Healthcare companies in United States.
Market cap
$282 MThe total market value of all of InfuSystem Holdings, Inc.'s shares at today's price (share price × number of shares), smaller than 53% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$59 MWhat InfuSystem Holdings, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$2.97Net worth divided by the number of shares. The share price of $14.14 is 4.8 times this, which is the P/B above.
Return on equity (ROE)
15.0%InfuSystem Holdings, Inc. earned 15.0% on its shareholders' money over the last year, higher than 87% of Healthcare companies in United States.
Owes vs Owns
0.39×InfuSystem Holdings, Inc. owes $0.39 for every $1 it owns (low), lower than 52% of Healthcare companies in United States.
Dividend yield
NoneInfuSystem Holdings, Inc. does not currently pay a dividend.
Revenue growth
+6%Revenue rose 6% in the year to Dec 2025, and grew 9% a year on average over 3 years.
Profit growth
+183%Net profit rose 183% in the year to Dec 2025, and grew 617% a year on average over 3 years.
Profit margin
4.6%InfuSystem Holdings, Inc. keeps $5 of every $100 of revenue as net profit.
Cash quality
3.7×Cash from InfuSystem Holdings, Inc.'s business was 3.7× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
9.2×InfuSystem Holdings, Inc.'s operating profit covered its interest costs 9.2 times in the year to Dec 2025.
Cash vs debt
Net debtInfuSystem Holdings, Inc. had $20 M more debt than cash (net debt) at Dec 2025.
Questions
What is InfuSystem Holdings, Inc.'s P/E ratio?
Investors pay $35.4 for every $1 of InfuSystem Holdings, Inc.'s yearly profit, higher than 64% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For InfuSystem Holdings, Inc.: $282 M ÷ $59 M (30 Jun 2026) = 4.8.
What is InfuSystem Holdings, Inc.'s return on equity?
InfuSystem Holdings, Inc. earned 15.0% on its shareholders' money over the last year, higher than 87% of Healthcare companies in United States.
How much does InfuSystem Holdings, Inc. owe compared with what it owns?
InfuSystem Holdings, Inc. owes $0.39 for every $1 it owns (low), lower than 52% of Healthcare companies in United States.
Does InfuSystem Holdings, Inc. pay a dividend?
No. InfuSystem Holdings, Inc. does not currently pay a dividend.
Is InfuSystem Holdings, Inc.'s revenue growing?
Revenue rose 6% in the year to Dec 2025, and grew 9% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.